Business

Business
Business

Citi resets Marvell stock price target ahead of earnings

Marvell Technology (MRVL) shares have been on fire this year as semiconductor stocks rallied on booming demand. The stock is up roughly 195% year-to-date, helped by strong demand for AI chips, networking and data-center infrastructure.  This week, Marvell jumped more than 10% after expanding its custom silicon partnership with Alphabet’s Google. The agreement could significantly

Read More
Business

Low-cost airline exits entire market, cancels all flights

With a total metropolitan population of just under 860,000 people, the English city of Leeds is the fifth-largest city in the United Kingdom and the economic and administrative capital of the Yorkshire region (York is considered the historic and cultural capital). At approximately 200 miles north of London and 44 miles northwest of Manchester, Leeds

Read More
Business

ServiceNow investors must consider latest alert from Bank of America

Back in May, I covered Bank of America analyst Tal Liani’s initial Buy call on ServiceNow (NOW) with a $130 price target.  His core argument was that Artificial Intelligence (AI) is the strongest tailwind ServiceNow has ever seen, not an existential threat to its business. The stock hit that target. Liani came back with a

Read More
Business

Bank of America sends message on Capital One stock

Capital One Financial has spent more than a year integrating Discover while investors watch whether the massive acquisition can translate into faster growth and stronger returns. The latest monthly data gave Wall Street a mixed picture. Capital One (COF) posted healthy credit trends in July, but growth in its domestic card portfolio slowed from the

Read More
Business

IRS has good tax deduction news for workers

A lot of overtime workers filed their 2025 taxes this spring without completely knowing what they were doing. Not because they were careless. Because the IRS hadn’t given employers the tools to report the right number yet. So workers guessed — and some of those guesses were wrong. For 2026, that problem goes away. The

Read More
Business

Jim Cramer tells investors to consider buying tumbling market giant

Uber (UBER) is one of those stocks that honestly generates strong opinions from everyone. From drivers, riders, regulators, and investors, because most of us have interacted with its variety of services at some point. But for shareholders, the point is not whether Uber is popular or controversial. The real point is whether the business is

Read More
Business

Home Depot faces uphill battle amid a growing customer problem

Home Depot has been struggling to reverse a concerning customer trend that continues to impact sales, despite recent efforts to boost demand. In the second quarter of this year, the home improvement chain’s comparable U.S. sales increased by 1.3% year over year, according to its latest earnings report. However, its in-store foot traffic declined during

Read More
Business

Fashion giant closes another store amid retail shakeup

A familiar fashion name is quietly reshaping its retail footprint, with another store now shutting its doors permanently. The latest closure comes as the company reassesses how its stores fit into a changing retail landscape, making the shutdown part of a larger story that extends well beyond a single location. Founded in 1967 as a

Read More
Business

BofA reveals surprising reason to buy Zoom stock

Bank of America is getting bullish on Zoom Communications again as the software company pushes deeper into phone, contact center, and artificial intelligence products after years of post-pandemic normalization. Zoom Communications (ZM) was reinstated at Buy by BofA analyst Matt Bullock, who set a $130 price objective that implies roughly 24% upside from the $104.71

Read More
Business

135-year-old healthcare giant surges on cancer vaccine breakthrough

Merck just delivered news that could reshape how doctors treat one of the deadliest skin cancers.  The 135-year-old drugmaker, founded in 1891 and now based in Rahway, New Jersey, announced a milestone that oncologists have chased for years: a personalized cancer treatment that worked in a large, controlled study. Investors took notice, sending the blue-chip

Read More